Status:
UNKNOWN
Predictors for Recurrence of Atrial Fibrillation After Electrical Cardioversion
Lead Sponsor:
Vestre Viken Hospital Trust
Collaborating Sponsors:
Oslo University Hospital
Lund University
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
In patients with persistent atrial fibrillation (AF), electrical cardioversion is very effective in restoring sinus rhythm if modern, biphasic cardioverters are used. However, approximately 50 per cen...
Eligibility Criteria
Inclusion
- Patients \> 18 years referred for electrical cardioversion for persistent atrial fibrillation
- Signed, informed consent
Exclusion
- Patients \< 18 years
- Patients with paroxysmal atrial fibrillation
- Patients unwilling to participate or without consent competence
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT03346863
Start Date
November 1 2017
End Date
December 1 2023
Last Update
May 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bærum Hospital, Vestre Viken
Sandvika, Bærum, Norway, 1346